
Jason E Stout MD
Professor, Medicine, Duke University School of Medicine
Join to view full profile
2100 Erwin RdDurham, NC 27705
Phone+1 919-620-4467
Fax+1 919-613-6430
Dr. Stout is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- My clinical practice focuses on mycobacterial diseases, including tuberculosis and nontuberculous mycobacterial disease. I also see patients with HIV and general infectious disease problems.
My research focuses on the epidemiology, natural history, and treatment of tuberculosis and nontuberculous mycobacterial infections. I am also interested in the impact of HIV infection on mycobacterial infection and disease, and in examining health disparities as they relate to infectious diseases, particularly in immigrant populations.
Education & Training
Duke University HospitalFellowship, Infectious Disease, 2000 - 2002
Duke University HospitalResidency, Internal Medicine, 1996 - 1999
SUNY Upstate Medical UniversityClass of 1996
Certifications & Licensure
NC State Medical License 1997 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
- Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis
- Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection Start of enrollment: 2020 Apr 17
Publications & Presentations
PubMed
- Improved understanding of pulmonary Mycobacterium avium treatment will arise from focusing on patients.Christopher J Richards, Jason E Stout
Annals of the American Thoracic Society. 2026-04-01 - Trends in Coronavirus Disease 2019 Mortality Within a US Academic Health System, 2020-2025.Nicholas A Turner, Jason E Stout, Jeffrey D Jenks
Open Forum Infectious Diseases. 2026-03-01 - 1 citationsEpidemiology of Healthcare Facility-Associated Nontuberculous Mycobacteria From 2012 Through 2020 in a 10-Hospital Network in the United States.Arthur W Baker, Ricardo M La Hoz, Judith A Anesi, Jennie H Kwon, Anastasia I Wasylyshyn
Clinical Infectious Diseases. 2026-02-04
Other
- Tuberculous pericarditisStout J
http://www.uptodate.com/contents/tuberculous-pericarditis
UpToDate, Wolters Kluwer Health - 2012-08-22
Professional Memberships
- Member
- Member
- Fellow
Other Languages
- French, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









